Drugs for Cancer Chemotherapy

  1. What are the 4 major types of cancer drug therapy?
    • Chemotherapy
    • Immunotherapy
    • Targeted therapy
    • Hormone therapy
  2. What is the conventional or cytotoxic chemotherapy therapeutic goal
    Kill cancer cells by halting cell division
  3. Chemotherapy drugs that kill cancer cells only when they are dividing and in a specific part of the cell cycle are called ____?
    Cell-cycle specific
  4. What are cell-cycle specific chemotherapy drugs?
    Kill cancer cells when the cells are at a specific part of the cell cycle
  5. Chemotherapy drugs that kill cancer cells when they are anywhere in the cell cycle are called ____?
    Cell-cycle non-specific
  6. What are cell-cycle non-specific chemotherapy drugs?
    The kill cancer cells anywhere in the cell cycle
  7. What is the major mechanism of action for chemotherapy drugs?
    • Interfere with DNA synthesis
    • Interesting with cell replication resulting in cell death
  8. True/False: cell cycle non-specific agents are active regardless of the phase of the cell cycle, as long as the cells are dividing
    True
  9. True/False: cell cycle specific agents require cells to be in a certain part of the cell cycle
    True
  10. True/False: cell cycle specific agents are most effective against rapidly gorwing tumors
    True
  11. What is neoadjuvant chemotherapy?
    Make a tumor smaller prior to surgery or radiation therapy
  12. What is adjuvant chemotherapy?
    Destroy cancer cells that remain AFTER treatment with surgery or radiation therapy
  13. True/False: neoadjuvant chemotherapy is given after surgery or radiation
    False; neoadjuvant is given BEFORE surgery or radiation
  14. True/False: adjuvant chemotherapy is given prior to surgery or radiation therapy
    False; adjuvant chemotherapy is given AFTER surgery or radiation to kill remaining cancer cells
  15. Palliative chemotherapy ______(does/does not) have curative effect.
    Does not
  16. Salvage chemotherapy is given to patients who are ______(responding/not responding) to or not tolerating primary chemotherapy
    Not responding
  17. What is the mechanism of action for immunotherapy?
    • Uses checkpoint inhibitor to increase our natural immunity ability to destroy cancer cells.
    • Bind to PDL1 on tumor cell or PD-1 receptors on T cell
  18. Which cancer drug therapy uses checkpoint inhibitor?
    Immunotherapy
  19. What is checkpoint inhibitor?
    Blocks Programmed death ligand receptor on tumor cells so they cannot bind to T cell
  20. What is targeted chemotherapy ?
    targets the changes in cancer cells that help them grow
  21. Which cancer drug therapy utilizes biomarker testing of tumor to ID the presence of various aggressive growth factors that can be inhibited with medications?
    Targeted therapy
  22. True/False: EGFR overactivity causes new cancer cells to form quickly
    True
  23. True/False: VEGF triggers angiogenesis
    True
  24. What is hormone therapy?
    Treatment that slows or stops the growth of breast and prostate cancers
  25. What is a common name stem for platinum chemotherapy drugs?
    Ends in -platin
  26. The name stem -platin is which type of chemotherapy drug?
    Platinum
  27. What are the agents of platinum drugs?
    • Cisplatin
    • Carboplatin
    • Oxaliplatin
  28. Which of the platinum drugs are commonly used for in lung cancer
    • Cisplatin
    • Carboplatin
  29. Which type of cancer is oxaliplatin used for?
    Colorectal cancer
  30. Cisplatin and Carboplatin are most commonly used for _______ cancer
    Lung
  31. True/False: platinum drugs are non cell-cycle specific
    True
  32. What is the mechanism of action for platinum drugs?
    • Intracellular activation via aquation of leaving groups
    • Binds to proteins, lipids, RNA and mitochondrial DNA – inhibiting DNA synthesis
  33. Which chemotherapy binds to proteins, lipids, RNA, mitochondrial DNA in order to stop DNA biosynthesis?
    Platinums
  34. True/False: carboplatin is less nephrotoxic than cisplatin and often given to patient who cannot tolerate cisplatin
    True
  35. What are common toxicities for cisplatin?
    • Nausea/vomiting
    • Nephrotoxicity
    • Cation wasting
    • Increase LFTs and bilirubin
    • Auditory impairment
  36. True/False: nausea and vomiting is a common side effect for cisplatin
    True
  37. True/false: Cation wasting: commonly Ca2+ and Na+ , is associated with cisplatin use
    False ; Cation Wasting most commonly refers to Mg2+ and K+
  38. Which cations do “cation wasting” refer to?
    • Mg2+
    • K+
  39. What are common side effects seen with carboplatin use?
    • Hematologic effects- carboplatin affects bone marrow
    • Myelosuppression
  40. True/False: carboplatin use affects bone marrow
    True
  41. What are common side effects with oxaliplatin use?
    Neuropathy
  42. True/false: neuropathy is often seen with oxaliplatin use
    True
  43. Which platinum drug is usually associated with nausea and vomiting?
    Cisplatin
  44. Which platinum drug is usually associated with cation wasting?
    Cisplatin
  45. Which platinum drug is usually associated with elevated LFT and bilirubin?
    Cisplatin
  46. Which platinum drug is usually associated with auditory impairment?
    Cisplatin
  47. Which platinum drug is usually associated with nephrotoxicity?
    Cisplatin
  48. Which platinum drug is usually associated with neuropathy?
    Oxaliplatin
  49. Which platinum drug is usually associated with myelosuppression?
    Carboplatin
  50. True/False: when Nausea/vomiting is a side effect (ie. With cisplatin), premedication is also warranted
    True
  51. What are the agents used as premedication to mediate n/v?
    • Dexamethosome 4mg PO BID, 3 days after chemo
    • Antiemetics PRN L prochlorperazine, ondansetron, lorazepam
  52. True/False: nephrotoxicity (ie with cisplatin use) can cause renal tubular damage
    True
  53. To combat nephrotoxicity side effect, cisplatin is usually given with ______
    IV hydration
  54. True/False: with oxaliplatin use, patients often get cold sensitivity secondary to neuropathy
    True
  55. What are some major toxicities with cisplatin use?
    • Seizure
    • Visual impairment
    • Hypersensitivity
    • Encephalopathy
  56. What are some major toxicities with carboplatin use?
    • Visual impairment
    • Hypersensitivity
  57. What are some major toxicities with oxaliplatin use?
    • Neuropathy
    • Hemolytic anemia
    • Hypersensitivity
    • Pulmonary fibrosis
  58. True/False: cisplatin is dosed using Calvert equation (area under curve)
    False; it is carboplatin that is dosed using that
  59. What is a common name for microtubule inhibitors?
    Taxanes
  60. What is the mechanism of action for taxanes?
    Inhibit depolymerization and enhances polymerization of microtubules
  61. What is microtubule?
    • Maintain cell shape
    • Component of mitotic spindle
  62. True/False: taxanes are cell cycle specific drug
    True
  63. Which cell cycle does taxnes target?
    G2/M phase
  64. “Mitotic spindle poison” is the mechanism for which anticancer drug?
    Taxanes
  65. What are the agents for Taxanes?
    • Paclitaxel
    • Protein bound Paclitaxel
    • Docetaxel
    • Cabazitaxel
  66. Cremophor vehicle is in which drug?
    Paclitaxel
  67. True/false: Paclitaxel is associated with hypersensitivity reactions
    True
  68. True/False: Paclitaxel is associated with myelosuppression
    True
  69. Which anticancer drug often results in abnormal EKG changes: sinus bradycardia?
    Paclitaxel
  70. True/false: albumin-bund paclitaxel is associated with hypersensitivity reactions
    False; albumin bound is the only taxane that does not have any infusion reactions
  71. True/False: Docetaxel is associated with hypersensitivity reactions
    True
  72. What are common toxicities with taxens?
    • Myelosuppression
    • Neuropathy
    • Hypersensitivity reactions
    • Diarrhea
    • Some nausea/vomiting
  73. True/False: taxanes are metabolized by the liver CYP450, so need to watch for drug-drug interaction
    True
  74. True/false: taxnes are associated with diarrhea
    True
  75. Which Taxane is not associated with hypersensitivity reactions?
    Albumin-bound paclitaxel
  76. What are major toxicities with paclitaxel?
    • Cardiac toxicity
    • Stevens-johnson syndrome
    • Hypersensitivity reactions
    • Seizure
    • Pulmonary embolism
  77. What are major toxicities with album paclitaxel?
    • Cardiac toxicity
    • Pulmonary embolism
  78. What are major toxicities with docetaxel?
    • Fluid retention
    • Stevens-Johnson syndrome
    • Pulmonary embolism
    • Colitis
  79. Which taxane has a major toxicity risk for Stevens-Johnson syndrome?
    • Paclitaxel
    • Docetaxel
  80. True/False: paclitaxel, docetaxel, and album-bound paclitaxel have pulmonary embolism as one of the major toxicities risk
    True
  81. True/False: administer taxanes after platinum compounds
    False; taxanes should be administered BEFORE platinum compounds
  82. What is the difference between topoisomerase I and II inhibitors?
    • Topoisomerase I breaks one strand of DNA
    • Topoisomerase II breaks two strands of DNA
  83. True/False: topoisomerase I inhibitor is a cell cycle non-specific anticancer drug?
    False; topoisomerase I is cell cycle specific
  84. Which cell cycle does topoisomerase I inhibitor drugs specific to?
    S- phase specific
  85. What is a prototype of topoisomerase I inhibitor?
    • Camptothecin
    • Topotecan
    • Irinotecan
  86. True/false: camptothecins irreversibly bind to topoisomerase I
    True
  87. What is the route of administration for Topotecan, and which one is more commonly used?
    • IV and oral
    • IV is more commonly used
  88. What is an adverse reaction with oral Topotecan use?
    Diarrhea common with oral form
  89. What type of drug is topotecan and camptothecin?
    Topoisomerase I inhibitors
  90. What type of drug is irinotecan?
    Topoisomerase I inhibitor
  91. What are adverse reactions associated with irinotecan?
    • Abdominal pain
    • Cramping
    • Diarrhea
  92. True/false: irinotecan is associated with diarrhea
    True
  93. Which metabolite is responsible for cytotoxicity in irinotecan activation?
    • SN-38
    • (don’t really know what this question is even asking)
  94. True/false: too much diarrhea for too long could kill you, like in the case with irinotecan use
    True; due to electrolyte abnormalities, dehydration, sepsis
  95. True/false: topotecan and irinotecan both have myelosuppression as a side effect
    true
  96. which of the two causes more nausea: topotecan or irinotecan
    irinotecan
  97. What are the two forms of topoisomerase II inhibitors?
    Alpha and beta
  98. Which cell cycle do alpha form of topoisomerase II inhibitor target?
    G2/M phase
  99. Which cell cycle do beta form of topoisomerase II inhibitor target?
    Throughout the cell cycle
  100. True/False: Topoisomerase II prevent cells from going into meiosis
    False; its mitosis. Topoisomerase II inhibitors arrest cells in G2 phase
  101. True/False: topoisomerase II inhibitors bind directly to DNAA
    False; they do not bind directly to DNA
  102. What is a prototype for topoisomerase II inhibitor?
    Etoposide
  103. What are some common toxicities for etoposide?
    • Myelosuppression
    • Mild n/v
    • Diarrhea
    • Fever/chills
    • Hypersensitivity reactions
  104. What are major toxicities for irinotecan?
    • Diarrhea
    • GI perforation
    • Interstitial lung disease
  105. What are major toxicities for topotecan?
    • Diarrhea (though rare)
    • Interstitial lung disease
  106. What are major toxicities for etoposide?
    • Hepatotoxicity
    • CHF
    • Stevens Johnson syndrome
  107. True/false: all topoisomerase inhibitors are associated with dose limiting myelosuppression
    True
  108. True/false: etoposide is associated with hypersensitivity reactions
    True
  109. True/false: irinotecan carries the risk of secondary malignancies
    False; etoposide carries the risk of secondary malignancies
Author
lykthrnn
ID
345778
Card Set
Drugs for Cancer Chemotherapy
Description
Pulmonary Final- Pharmacology
Updated